Lord, Abbett & Co. LLC Trillium Therapeutics Inc. Transaction History

Lord, Abbett & Co. LLC

  • $28.1 Billion
  • Q1 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021
SELL
N/A
-847,785 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
N/A
-80,862 Reduced 8.71%
847,785 $8.22 Million
Q1 2021

May 11, 2021
BUY
N/A
334,135 Added 56.2%
928,647 $9.97 Million
Q4 2020

Feb 09, 2021
BUY
N/A
263,673 Added 79.7%
594,512 $8.75 Million
Q3 2020

Nov 12, 2020
BUY
N/A
330,839 New
330,839 $4.7 Million

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email